Sanofi’s belated admission of a lethal Dengvaxia threat came long after multiple high-profile warnings
Philippine health officials administering Dengvaxia earlier this year Sipa, AP Images
Late last week, the Philippine government woke up to a public health crisis it had played a major role in creating.
It began on April 4 last year, when health officials launched a dengue vaccination program that would aggressively seek out more than 700,000 people — including tens of thousands of children 9 and up — for $70 million worth of Sanofi’s newly approved Dengvaxia.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
